טוען...
Extensive Gray Matter Volume Reduction in Treatment-Resistant Schizophrenia
BACKGROUND: Approximately one-third of people with schizophrenia are treatment-resistant and some do not achieve remission with clozapine, the gold-standard antipsychotic medication for treatment-resistant schizophrenia. This study compared global and regional brain volumes between treatment-respond...
שמור ב:
| הוצא לאור ב: | Int J Neuropsychopharmacol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4540109/ https://ncbi.nlm.nih.gov/pubmed/25716781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv016 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|